# Task A: Early Phase Clinical Trial Units (EPCTU)

> **NIH NIH N01** · DYNPORT VACCINE COMPANY, LLC · 2024 · $212,105

## Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

## Key facts

- **NIH application ID:** 11042110
- **Project number:** 75N93022D00016-P00002-759302200001-1
- **Recipient organization:** DYNPORT VACCINE COMPANY, LLC
- **Principal Investigator:** GEORGE SAVIOLAKIS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $212,105
- **Award type:** —
- **Project period:** 2022-01-14 → 2025-01-13

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11042110

## Citation

> US National Institutes of Health, RePORTER application 11042110, Task A: Early Phase Clinical Trial Units (EPCTU) (75N93022D00016-P00002-759302200001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11042110. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*